Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of ...
March Biosciences (March Bio), an emerging clinical stage biotechnology company committed to combating challenging cancers and other diseases, today announced that interim clinical data from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback